Form 4: National Health Investors CEO Exercises Stock Options, Acquires Shares
SEC Form 4 Filing
CEO D. Eric Mendelsohn acquired shares of National Health Investors through the exercise of stock options, with shares withheld to cover the exercise price and taxes.
Summary
- D. Eric Mendelsohn, CEO and President of National Health Investors Inc., executed stock options on September 5, 2024.
- The transactions involved the acquisition of common stock through the exercise of stock options granted on February 25, 2022, February 24, 2023, and February 23, 2024.
- A total of 130,461 shares were withheld by the company to cover the exercise price and associated taxes.
- The exercise prices for the options ranged from $53.41 to $57.76.
- Following the reported transactions, Mendelsohn directly owns 88,794 shares of common stock.
- The acquired shares are subject to a Lock-Up Agreement.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Positives
- The CEO's exercise of stock options could be interpreted as a positive signal, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. The exercise of stock options is a typical form of executive compensation.
Stakeholder Impact
- The CEO's increased stake in the company could align his interests more closely with those of shareholders.
Key Dates
| Date | Description |
|---|---|
| 02/21/2020 | Date of grant for some stock options with an exercise price of $90.79. |
| 02/25/2021 | Date of grant for some stock options with an exercise price of $69.2. |
| 02/25/2022 | Date of grant for some stock options with an exercise price of $53.41. |
| 02/24/2023 | Date of grant for some stock options with an exercise price of $54.73. |
| 02/23/2024 | Date of grant for some stock options with an exercise price of $57.76. |
| 09/05/2024 | Date of transaction: CEO exercised stock options and acquired shares. |
| 09/06/2024 | Date of filing of the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.